- Home
- ZBIO vs CIVB Comparison
ZBIO vs CIVB Comparison
Compare ZBIO & CIVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBIO
- CIVB
- Stock Information
- Founded
- ZBIO 2019
- CIVB 1884
- Country
- ZBIO United States
- CIVB United States
- Employees
- ZBIO N/A
- CIVB N/A
- Industry
- ZBIO
- CIVB Major Banks
- Sector
- ZBIO
- CIVB Finance
- Exchange
- ZBIO NYSE
- CIVB Nasdaq
- Market Cap
- ZBIO 389.2M
- CIVB 349.3M
- IPO Year
- ZBIO 2024
- CIVB N/A
- Fundamental
- Price
- ZBIO $9.09
- CIVB $23.37
- Analyst Decision
- ZBIO Strong Buy
- CIVB Buy
- Analyst Count
- ZBIO 7
- CIVB 4
- Target Price
- ZBIO $32.29
- CIVB $25.67
- AVG Volume (30 Days)
- ZBIO 147.9K
- CIVB 39.9K
- Earning Date
- ZBIO 05-27-2025
- CIVB 04-24-2025
- Dividend Yield
- ZBIO N/A
- CIVB 2.94%
- EPS Growth
- ZBIO N/A
- CIVB N/A
- EPS
- ZBIO N/A
- CIVB 2.26
- Revenue
- ZBIO $5,000,000.00
- CIVB $153,524,000.00
- Revenue This Year
- ZBIO N/A
- CIVB $17.44
- Revenue Next Year
- ZBIO N/A
- CIVB $5.37
- P/E Ratio
- ZBIO N/A
- CIVB $10.25
- Revenue Growth
- ZBIO N/A
- CIVB 2.34
- 52 Week Low
- ZBIO $5.83
- CIVB $13.60
- 52 Week High
- ZBIO $26.25
- CIVB $23.70
- Technical
- Relative Strength Index (RSI)
- ZBIO N/A
- CIVB 68.90
- Support Level
- ZBIO N/A
- CIVB $21.58
- Resistance Level
- ZBIO N/A
- CIVB $23.53
- Average True Range (ATR)
- ZBIO 0.00
- CIVB 0.97
- MACD
- ZBIO 0.00
- CIVB 0.10
- Stochastic Oscillator
- ZBIO 0.00
- CIVB 94.35
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
About CIVB Civista Bancshares Inc.
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.